BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
Religare Downgrades Torrent Pharma to Sell
Religare has downgraded Torrent Pharma to 'sell' from 'hold' with a target price of Rs 1,000. The brokerage says that the stock trades at high valuation of 22.7 times its FY17 forward earnings. Religare expects limited upside from here on and see untenable long-term drivers.